Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	3370	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	3615	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	3920	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	4020	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	4233	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	4297	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	4636	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	4723	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	4741	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	4837	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	4946	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	4972	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	5083	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	5088	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	5147	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	5261	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	5264	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	5339	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	5763	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	5895	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	6167	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	6295	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	6337	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	6344	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	6649	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	6730	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	6762	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	6779	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	6834	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	6930	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	7193	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	7253	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	7505	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	7529	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	8398	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	8439	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	9117	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	9343	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-	11952	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M-H)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	5674	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	6429	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	6845	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	7538	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	8216	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	8319	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	8997	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	9080	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	10126	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	10313	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	10794	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	12074	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	13100	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	14136	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	14706	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	15138	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	15569	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	18550	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	18815	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+	20060	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GLUTAMINE (CAS# 56-85-9); (M+NA)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y